DEA Intends to Restrict Imports and Exports of Three Synthetic Substances
The Drug Enforcement Administration has issued notice of its intent to temporarily place the following three synthetic phenethylamines into Schedule I of the Controlled Substances Act.
- 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5)
- 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82)
- 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36)
A final order, which could be published and take effect as early as Nov. 12, would impose the administrative, civil and criminal sanctions and regulatory controls applicable to Schedule I substances under the CSA on the manufacture, distribution, possession, importation, exportation, research, and conduct of instructional activities of these substances. This order would remain in effect for two years and could be extended one additional year.
According to the DEA, these substances were developed over the last decade for use in mapping and investigating the serotonin receptors in the mammalian brain. However, published studies and law enforcement reports document that these substances are being abused in various ways and are purported to be hallucinogens. U.S. Customs and Border Protection data reveal that bulk quantities of these substances in powdered form have been seized from shipments originating overseas, particularly in Asia.